Investigating the effects of e-cigarette inhalation on heart and lung health
E-cigarette Inhalation and Cardiopulmonary Dysfunction
This study is looking at how breathing in e-cigarette vapor might affect your heart and lungs, using mice to see if long-term exposure could lead to health issues like high blood pressure and problems with blood vessels, so we can better understand the risks of using e-cigarettes compared to regular cigarettes.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Lsu Health Sciences Center NIH-funded |
| Lab location | 1 site (New Orleans, United States) |
| Project ID | NIH-11055978 on NIH RePORTER |
What this research studies
This research focuses on understanding how inhaling e-cigarette vapor affects the heart and lungs. Using a mouse model, the study examines the impact of chronic exposure to e-cigarette vapor on cardiopulmonary function and the activation of biological systems that regulate blood pressure and vascular health. The research aims to uncover the potential risks associated with e-cigarette use, particularly in relation to conditions like pulmonary hypertension and vascular dysfunction. By analyzing these effects, the study seeks to provide insights into the safety of e-cigarettes compared to traditional smoking.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who use e-cigarettes or are considering their use, particularly those with existing cardiovascular or pulmonary conditions.
Not a fit: Patients who do not use e-cigarettes and have no interest in nicotine products may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to a better understanding of the health risks associated with e-cigarette use, potentially informing public health policies and smoking cessation strategies.
How similar studies have performed: Previous research has indicated that nicotine exposure can lead to significant cardiovascular and pulmonary issues, suggesting that this study builds on established findings rather than exploring a completely novel area.
Where this research is happening
New Orleans, United States
- Lsu Health Sciences Center — New Orleans, United States (Active)
Researchers
- Principal investigator: Whitehead, Anna Kathryn — Lsu Health Sciences Center
- Study coordinator: Whitehead, Anna Kathryn
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.